Compounds > diclofenac

diclofenac and trinitrobenzenesulfonic acid

diclofenac has been researched along with trinitrobenzenesulfonic acid in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barbosa, DS; Breganó, JW; Cecchini, R; Dichi, I; Dichi, JB; El Kadri, MZ; Matsuo, T; Rodrigues, MA	1
de Oliveira Costa, H; Franco, M; Miszputen, SJ; Oshima, CT; Paiotti, AP; Ribeiro, DA	1
Franco, M; Marchi, P; Miszputen, SJ; Neto, RA; Oshima, CT; Paiotti, AP; Ribeiro, DA; Silva, RM	1

Other Studies

3 other study(ies) available for diclofenac and trinitrobenzenesulfonic acid

Article	Year
Decreased total antioxidant capacity in plasma, but not tissue, in experimental colitis. Digestive diseases and sciences, 2009, Volume: 54, Issue:4 Topics: Animals; Antioxidants; Biomarkers; Colitis; Colon; Cyclooxygenase Inhibitors; Diclofenac; Male; Oxidative Stress; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid	2009
Effect of COX-2 inhibitor after TNBS-induced colitis in Wistar rats. Journal of molecular histology, 2009, Volume: 40, Issue:4 Topics: Animals; Cyclooxygenase 2 Inhibitors; Diclofenac; Disease Models, Animal; Inflammatory Bowel Diseases; Rats; Rats, Wistar; RNA, Messenger; Trinitrobenzenesulfonic Acid	2009
Effect of COX-2 inhibitor lumiracoxib and the TNF-α antagonist etanercept on TNBS-induced colitis in Wistar rats. Journal of molecular histology, 2012, Volume: 43, Issue:3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Disease Models, Animal; Down-Regulation; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Male; Random Allocation; Rats; Rats, Wistar; Receptors, Tumor Necrosis Factor; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha	2012